Ovation Science (XCNQ:OVAT) Gross Margin % : 66.67% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Ovation Science Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Ovation Science's Gross Profit for the three months ended in Dec. 2023 was C$0.01 Mil. Ovation Science's Revenue for the three months ended in Dec. 2023 was C$0.02 Mil. Therefore, Ovation Science's Gross Margin % for the quarter that ended in Dec. 2023 was 66.67%.

The historical rank and industry rank for Ovation Science's Gross Margin % or its related term are showing as below:

XCNQ:OVAT' s Gross Margin % Range Over the Past 10 Years
Min: 73.07 Med: 86.26 Max: 97.83
Current: 88.71

During the past 7 years, the highest Gross Margin % of Ovation Science was 97.83%. The lowest was 73.07%. And the median was 86.26%.

XCNQ:OVAT's Gross Margin % is ranked better than
96.75% of 986 companies
in the Drug Manufacturers industry
Industry Median: 46.51 vs XCNQ:OVAT: 88.71

Ovation Science had a gross margin of 66.67% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Ovation Science was 1.00% per year.

Ovation Science Gross Margin % Historical Data

The historical data trend for Ovation Science's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovation Science Gross Margin % Chart

Ovation Science Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Margin %

Get a 7-Day Free Trial

94.04

73.07

83.56

97.83

87.10

Ovation Science Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross Margin %	Get a 7-Day Free Trial															-	-	50.00	75.00	66.67

Competitive Comparison of Ovation Science's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Ovation Science's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ovation Science's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ovation Science's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Ovation Science's Gross Margin % falls into.

Ovation Science Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Ovation Science's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	0.1	/	0.062
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.062 - 0.008)	/	0.062
	=	87.10 %

Ovation Science's Gross Margin for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	0.015
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.015 - 0.005)	/	0.015
	=	66.67 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Ovation Science (XCNQ:OVAT) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Ovation Science had a gross margin of 66.67% for the quarter that ended in Dec. 2023 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Ovation Science Gross Margin % Related Terms

Thank you for viewing the detailed overview of Ovation Science's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ovation Science (XCNQ:OVAT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ovation Science Inc (XCNQ:OVAT) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

OVATF:USA

Address

625 Howe Street, Suite 1140, Vancouver, BC, CAN, V6C 2T6

Website

https://www.ovationscience.com

Ovation Science Inc is a Canada-based company mainly engaged in the business of sub-licensing rights to use Invisicare, a patented drug delivery technology used in topical and transdermal skin products containing hemp seed oil and cannabis products. The company also holds the right to manufacture, distribute, sell, market, sub-license and promote products formulated with Invisicare and containing cannabis products including cannabinoids, hemp seed oil and any synthetic derivatives of cannabis. It also develops formulas for skin product lines including topical and transdermal creams and lotions containing hemp seed oil and cannabis.

Executives

David K. Ryan

Director

Ovation Science (XCNQ:OVAT) Headlines

No Headlines